ARTICLE SUMMARY:
The global market for injectable and infusion drug delivery devices is mature. The biggest prospects for Western companies’ growth come largely from geographic expansion into Asia and non-Western countries, as well as modest technological innovations that improve systemic costs and error rates, and favorable demographics.
Favorable demographics, government reforms in the US and elsewhere aimed at expanding access to healthcare, a steady pace of incremental technological advances, and growing demand in emerging markets form the backbone of modest growth in the global drug delivery industry for the foreseeable future.
